Catheter for thromboembolic disease with mechanic waves, injection and ejection

Abstract

A catheter for thromboembolic disease with mechanic waves, injection, and ejection having a triple-lumen catheter system, whereby a first lumen is for injection, a second lumen is for ejection, and a third lumen has a mechanical wave emitter for wave emissions. The first lumen, the second lumen, and the third lumen are longitudinal, whereby the first lumen and the second lumen are symmetrical and opposite each other, and the third lumen is positioned approximately at a center of the triple lumen catheter system.

Claims

1. A catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection, comprising: a triple-lumen catheter having a first lumen for injection, a second lumen for ejection, and a third lumen having a mechanical wave emitter for waves emission, wherein said triple-lumen catheter comprises a catheter body, a proximal end, and a distal end, said proximal end has a port assembly connected thereto, said port assembly having an injection portion, an ejection port, and an emission port, wherein said mechanical wave emitter is flexible and comprises a horn unit and first and second wires, wherein said mechanical waver emitter emits or releases sound waves, and wherein said horn unit is protruding from said distal end and is configured to release said sound waves into a blood vessel, wherein said first lumen for injection is configured to inject an anticoagulant solution into said blood vessel, said first lumen is defined by a first peripheral semicircular wall, a first interior semicircular wall, and first and second radial walls, wherein said first peripheral semicircular wall and said first interior semicircular walls are concentric, wherein said second lumen is defined by a second peripheral semicircular wall, a second interior semicircular wall, and said first and second radial walls, wherein said second peripheral semicircular walls and second interior semicircular wall are concentric, and wherein said first interior semicircular wall and said second interior semicircular wall define said third lumen, said third lumen is approximately positioned at a center of said triple-lumen catheter, wherein said third lumen for mechanical wave emissions is surrounded by said first and second semicircular lumens.

2. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 1, further characterized in that said first lumen, said second lumen, and said third lumen are longitudinal.

3. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 1, further characterized in that said first lumen and said second lumen are symmetrical and opposite to each other.

4. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 1, further characterized in that said first lumen and said second lumen are hollow.

5. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 1, further characterized in that said sound waves are configured to break up and/or destroy a blood clot/thrombus.

6. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 5, further characterized in that said second lumen is configured for ejection of residue and matter from said blood clot/thrombus and said anticoagulant solution.

7. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 5, further characterized in that said first lumen for injection, said mechanical wave emitter and said second lumen for ejection are configured to simultaneously destroy, suction and extract out said blood clot/thrombus from a blood vessel.

8. The catheter system for treating thromboembolic disease with mechanical waves, injection, and ejection set forth in claim 7, further characterized in that said sound waves have a frequency between 19 Hertz-19 Kilo Hertz.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) With the above and other related objects in view, the invention consists in the details of construction and combination of parts as will be more fully understood from the following description, when read in conjunction with the accompanying drawings in which:

(2) FIG. 1 is an isometric view of the present invention.

(3) FIG. 2 is an isometric view of the present invention connected to respective injection device, ejection device, and wave emitter device.

(4) FIG. 3 is a cross-section view taken along lines 3-3 from FIG. 1.

(5) FIG. 4 is an isometric view of the present invention showing a mechanical wave emitter.

(6) FIG. 5A is a cross-section view of the present invention presented into a blood vessel having a blood clot.

(7) FIG. 5B is a cross-section view of the present invention presented into the blood vessel in a first stage of blood clot dissolution and ejection.

(8) FIG. 5C is a cross-section view of the present invention presented into the blood vessel in a second stage of the blood clot dissolution and ejection.

(9) FIG. 5D is a cross-section view of the present invention presented into the blood vessel in a third stage of the blood clot dissolution and ejection.

(10) FIG. 5E is a cross-section view of the present invention presented into the blood vessel in a fourth stage of the blood clot dissolution and ejection.

(11) FIG. 5F is a cross-section view of the present invention presented into a blood vessel when the blood clot has been completely dissolved and ejected.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

(12) Referring now to the drawings, the present invention is a catheter for thromboembolic disease with mechanic waves, injection and ejection, and is generally referred to with numeral 10. It can be observed that it basically includes triple-lumen catheter system 20 having first lumen 40, second lumen 60, and third lumen 80.

(13) As seen in FIGS. 1 and 2, triple-lumen catheter system 20 comprises catheter body 22, proximal end 24, and distal end 26. Proximal end 24 is connected to port assembly 30. First lumen 40, second lumen 60, and third lumen 80 are longitudinal. Port assembly 30 comprises injection port 32, ejection port 34, and emission port 36. Injection port 32 receives injection device ID and interconnects with first lumen 40. Ejection port 34 connects with ejection device ED having container C, and interconnects with second lumen 60. Emission port 36 is connected to wave emitter device WE, whereby mechanical wave emitter 90 passes through third lumen 80.

(14) As seen in FIG. 3, first peripheral semicircular wall 42, first interior semicircular wall 46, and first and second radial walls 50 and 50 define first lumen 40. First peripheral semicircular wall 42 and first interior semicircular wall 46 are concentric. Second peripheral semicircular wall 62, second interior semicircular wall 66, and first and second radial walls 50 and 50 define second lumen 60. Second peripheral semicircular wall 62 and second interior semicircular wall 66 are also concentric. First interior semicircular wall 46 and second interior semicircular wall 66 define third lumen 80 positioned approximately at a center of triple-lumen catheter system 20.

(15) As seen in FIG. 4, first lumen 40 and second lumen 60 are symmetrical and opposite to each other. In a preferred embodiment, first lumen 40 and second lumen 60 are hollow. Mechanical wave emitter 90 comprises first and second wires 92 and 94, and horn unit 96, seen in FIGS. 1 and 2. Mechanical wave emitter 90 is flexible. In a preferred embodiment, mechanical wave emitter 90 emits or releases sound waves W as seen in FIGS. 5B, 5C, and 5D.

(16) As seen in FIG. 5A, present invention 10 is inserted into blood vessel BV having blood clot/thrombus BC.

(17) As seen in FIGS. 5A and 5B, triple-lumen catheter system 20 comprises first lumen 40 for injection, second lumen 60 for ejection, and third lumen 80, seen in FIGS. 3 and 4, that has mechanical wave emitter 90 to emit or release sound waves W into blood vessel BV. In a preferred embodiment, horn unit 96 slightly protrudes from distal end 26 to emit or release sound waves W.

(18) As seen in FIGS. 5B, 5C, and 5D, first lumen 40 delivers anticoagulant solutions AC inside blood vessel BV, which has blood clot/thrombus BC, while mechanical wave emitter 90 emits or releases sound waves W onto blood clot/thrombus BC. Second lumen 60 is for ejection of residue and matter from blood clot/thrombus BC, and thrombus and anticoagulant solution AC. The injection, ejection, and emission of sound waves W occur approximately simultaneously.

(19) As seen in FIGS. 5C and 5D, Sound waves W travel lengthwise to reach blood clot/thrombus BC, enhancing their impact with the help of anticoagulant solution AC injected through first lumen 40. Sound waves W increase a reaction speed between anticoagulant solution AC and blood clot/thrombus BC. Sound waves W propagate molecules with energy and velocities measurable within safe limits. In a preferred embodiment, sound wave frequencies used in present invention 10 are between 19 Hertz-19 Kilo Hertz. The wave frequency and sound wave energy may be graduated according to patient characteristics, but always between 19 Hertz-19 Kilo Hertz. Sound waves W and anticoagulant solution AC break up and destroy blood clot/thrombus BC and thrombus, typically in parts, while residue and matter from blood clot/thrombus BC, thrombus and anticoagulant solution AC are simultaneously removed/suctioned/extracted out from blood vessel BV through second lumen 60.

(20) As seen in FIGS. 5D and 5E, residue and matter from blood clot/thrombus BC, thrombus, and anticoagulant solution AC are removed/suctioned/extracted out once blood clot/thrombus BC is partially or totally broken up and/or destroyed. An ascendant spiral circulation is formed in front of blood clot/thrombus BC, removing/extracting the residue and matter of blood clot/thrombus BC out from blood vessel BV. This continues until blood clot/thrombus BC is completely broken up and/or destroyed and all the residue and matter is removed/suctioned/extracted from blood vessel BV.

(21) As seen in FIG. 5F, present invention 10 is then removed from blood vessel BV.

(22) Present invention 10 may be used to treat thrombi pathologies of the circulatory system, especially pulmonary thrombi embolisms, coronary bifurcations, and periphery circulation problems in the legs. Present invention 10 breaks up and/or destroys cholesterol plates, clot, and/or thrombus in combination with injection and ejection.

(23) The foregoing description conveys the best understanding of the objectives and advantages of the present invention. Different embodiments may be made of the inventive concept of this invention. It is to be understood that all matter disclosed herein is to be interpreted merely as illustrative, and not in a limiting sense.